Silva, S., Duarte, J., Simão, C., & Felizardo, M. (2025). Osimertinib: A Game-Changer in Stage IV EGFR-Driven Lung Cancer. Acta Médica Portuguesa, 38(9), 568–572. https://doi.org/10.20344/amp.22031